85 related articles for article (PubMed ID: 8383518)
1. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
Stoschitzky K; Egginger G; Zernig G; Klein W; Lindner W
Chirality; 1993; 5(1):15-9. PubMed ID: 8383518
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
Stoschitzky K; Kahr S; Donnerer J; Schumacher M; Luha O; Maier R; Klein W; Lindner W
Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077
[TBL] [Abstract][Full Text] [Related]
3. Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin).
Clementi WA; Garvey TQ; Clifton GD; McCoy RA; Brandt S; Schwartz S
Chirality; 1994; 6(3):169-74. PubMed ID: 8024947
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study.
Egginger G; Lindner W; Kahr S; Stoschitzky K
Chirality; 1993; 5(7):505-12. PubMed ID: 8240927
[TBL] [Abstract][Full Text] [Related]
5. Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies.
Stoschitzky K; Klein W; Stark G; Stark U; Zernig G; Graziadei I; Lindner W
Clin Pharmacol Ther; 1990 Jun; 47(6):740-6. PubMed ID: 2162749
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of reboxetine in healthy male volunteers.
Denolle T; Pellizzoni C; Jannuzzo MG; Poggesi I
Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064
[TBL] [Abstract][Full Text] [Related]
7. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
Paradiso-Hardy FL; Walker SE; Bowles SK
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
[TBL] [Abstract][Full Text] [Related]
8. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
[TBL] [Abstract][Full Text] [Related]
9. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective hemodynamic effects of (R)-and (S)-propranolol in man.
Stoschitzky K; Lindner W; Rath M; Leitner C; Uray G; Zernig G; Moshammer T; Klein W
Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):474-8. PubMed ID: 2739756
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers.
Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
J Clin Pharmacol; 1998 Dec; 38(12):1096-106. PubMed ID: 11301561
[TBL] [Abstract][Full Text] [Related]
12. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
[TBL] [Abstract][Full Text] [Related]
13. A stereoselective central hypotensive action of atenolol.
Pearson AA; Gaffney TE; Walle T; Privitera PJ
J Pharmacol Exp Ther; 1989 Sep; 250(3):759-63. PubMed ID: 2778713
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris.
van der Vijgh WJ; Majid PA; de Feyter PJ; Wardeh R; van der Wall EE
Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):375-7. PubMed ID: 7005122
[TBL] [Abstract][Full Text] [Related]
15. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
Stoschitzky K; Lindner W
Wien Med Wochenschr; 1990 Apr; 140(6-7):156-62. PubMed ID: 1971978
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
17. Effect of rifampicin on the pharmacokinetics of atenolol.
Lilja JJ; Juntti-Patinen L; Neuvonen PJ
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):555-8. PubMed ID: 16700816
[TBL] [Abstract][Full Text] [Related]
18. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
Główka FK; Caldwell J
Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
[TBL] [Abstract][Full Text] [Related]
19. Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure propranolol in the rat.
Bode W; Toet AE; Stolker AA; van Ginkel LA; Groen K; Wemer J; de Wildt DJ
Chirality; 1995; 7(8):626-31. PubMed ID: 8593256
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
